UK healthcare stakeholders publish clinical research best practice
This article was originally published in Scrip
The Ethical Standards in Health and Life Sciences Group (ESHLSG), representing leading UK healthcare organisations, including the medical Royal Colleges and senior representatives of the pharma industry, has published guidelines for best practice in transparency and publication of data arising from clinical research studies. This is the first time that these stakeholders have agreed to a joint approach and is being lauded as an important step forward in the ongoing move across the entire research community to pursue transparency in clinical research reporting.
You may also be interested in...
Cambridge, UK-based Healx has concluded a $56m series B round, led by Atomico, to put up to 50 potential rare disease treatments into the clinic within two years using its AI/ML platform.
Tapping into the ability of arenaviruses to deliver prolonged local immune activation, rapid regression of localized and metastatic cancers, and long-term disease control, Essen, Germany-based start-up Abalos Therapeutics has raised €12m to advance its lead candidates towards clinical testing.
Celgene agrees to pay $75m upfront for options to three Immatics TCR-T targets for solid tumors. Deal could be worth up to $1.59bn to the German biotech, which also retains option to co-develop and co-fund certain licensed products.